Literature DB >> 35601943

Double atypical co-infection in ecthyma gangrenosum: a peculiar case report.

Paulus Mario Christopher1, Erna Kristiani2.   

Abstract

Introduction: Ecthyma gangrenosum (EG) is a rare cutaneous manifestation commonly associated with Pseudomonas aeruginosa infection in immunocompromised individuals. Additionally, different bacterial and fungal pathogens have also been identified. However, co-infection on EG lesions has never been reported before. Case report: We present the case of a seven-year-old female Asian patient who initially was diagnosed with febrile neutropenia. Initially, on the sixth day of admission, dermatological status revealed multiple painless erythematous macules on the face and arms together with persistent fever followed by evolution to multiple black, deep-seated, and large central eschars and early identification of Pseudomonas aeruginosa in the blood culture. Further evaluation revealed the development of EG with XDR Acinetobacter baumannii and Aspergillus spp. isolated from the samples harvested intraoperatively. Conclusions: Specific identification of etiological agents will serve its importance for early diagnosis, aggressive antibiotic treatment, and/or surgical intervention to improve the prognosis. GERMS.

Entities:  

Keywords:  Acinetobacter baumannii; Pseudomonas aeruginosa; aspergillosis; ecthyma gangrenosum; immunocompromised

Year:  2022        PMID: 35601943      PMCID: PMC9113691          DOI: 10.18683/germs.2022.1314

Source DB:  PubMed          Journal:  Germs        ISSN: 2248-2997


  10 in total

1.  Ecthyma gangrenosum: a rare cutaneous manifestation caused by pseudomonas aeruginosa without bacteraemia in a leukaemic patient--a case report.

Authors:  T N Singh; K M Devi; K S Devi
Journal:  Indian J Med Microbiol       Date:  2005-10       Impact factor: 0.985

2.  Infection-related complications during treatment for childhood acute lymphoblastic leukemia.

Authors:  H Inaba; D Pei; J Wolf; S C Howard; R T Hayden; M Go; O Varechtchouk; T Hahn; J Buaboonnam; M L Metzger; J E Rubnitz; R C Ribeiro; J T Sandlund; S Jeha; C Cheng; W E Evans; M V Relling; C-H Pui
Journal:  Ann Oncol       Date:  2017-02-01       Impact factor: 32.976

Review 3.  Ecthyma gangrenosum and ecthyma-like lesions: review article.

Authors:  M Vaiman; T Lazarovitch; L Heller; G Lotan
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-11-19       Impact factor: 3.267

Review 4.  Acinetobacter baumannii-associated skin and soft tissue infections: recognizing a broadening spectrum of disease.

Authors:  Dubert M Guerrero; Federico Perez; Nicholas G Conger; Joseph S Solomkin; Mark D Adams; Philip N Rather; Robert A Bonomo
Journal:  Surg Infect (Larchmt)       Date:  2010-02       Impact factor: 2.150

Review 5.  Nonpseudomonal ecthyma gangrenosum.

Authors:  Hilary L Reich; Darice Williams Fadeyi; Narayan S Naik; Paul J Honig; Albert C Yan
Journal:  J Am Acad Dermatol       Date:  2004-05       Impact factor: 11.527

Review 6.  Acinetobacter baumannii: an emerging opportunistic pathogen.

Authors:  Aoife Howard; Michael O'Donoghue; Audrey Feeney; Roy D Sleator
Journal:  Virulence       Date:  2012-05-01       Impact factor: 5.882

Review 7.  Biology of Acinetobacter baumannii: Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment Options.

Authors:  Chang-Ro Lee; Jung Hun Lee; Moonhee Park; Kwang Seung Park; Il Kwon Bae; Young Bae Kim; Chang-Jun Cha; Byeong Chul Jeong; Sang Hee Lee
Journal:  Front Cell Infect Microbiol       Date:  2017-03-13       Impact factor: 5.293

8.  Localized ecthyma gangrenosum without sepsis in a neutropenic patient with a myelodysplastic syndrome-Refractory anemia with excess blasts type 2.

Authors:  Anaïs Zanella; Cyril Faure; Catherine Merle; Romain Charollais; François Aubin
Journal:  Clin Case Rep       Date:  2019-08-09

9.  Ecthyma gangrenosum mimicking cellulitis.

Authors:  Toru Ishihara; Hideki Ozawa
Journal:  Clin Case Rep       Date:  2021-01-01

10.  Correlation between Acinetobacter baumannii Resistance and Hospital Use of Meropenem, Cefepime, and Ciprofloxacin: Time Series Analysis and Dynamic Regression Models.

Authors:  Rania Kousovista; Christos Athanasiou; Konstantinos Liaskonis; Olga Ivopoulou; George Ismailos; Vangelis Karalis
Journal:  Pathogens       Date:  2021-04-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.